Table 3.
Autoantibodies positive for candidate tumor-associated antigens in colorectal cancer patients negative for CEA.
CEA | ALDH1B1 aAb | UQCRC1 aAb | CTAG1 aAb | CENPF aAb | ||
---|---|---|---|---|---|---|
CEA (+) | TAAb (+) | 37 (42.5%) | 24 (64.9%) | 23 (62.2%) | 21 (56.8%) | 24 (64.9%) |
TAAb (–) | 13 (35.1%) | 14 (37.8%) | 16 (43.2%) | 13 (35.1%) | ||
CEA (–) | TAAb (+) | 50 (57.5%) | 31 (62.0%) | 30 (60.0%) | 35 (70.0%) | 25 (50.0%) |
TAAb (–) | 19 (38.0%) | 20 (40.0%) | 15 (30.0%) | 25 (50%) |
aAb, autoantibody; CEA, carcinoembryonic antigen.